Jump to content

Talk:Hypomethylating agent

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Is use in Acute_myeloid_leukemia approved or off-label

[edit]

Both agents listed as approved for MDS also seem to be used for Acute_myeloid_leukemia.[1] Are they approved (anywhere) for (any) AML or is this use off-label (in the US) ? - Rod57 (talk) 12:36, 19 May 2016 (UTC)[reply]

EU approved decitabine in 2012 - but maybe off label in USA ? - Rod57 (talk) 11:07, 28 June 2017 (UTC)[reply]

References

  1. ^ 2016 AML review

Side-effects ?

[edit]

Do these agents have similar side-effects ? What are they ? How do they compare to other chemotherapies ? - Rod57 (talk) 12:36, 19 May 2016 (UTC)[reply]

Retrieved from "https://en.wikipedia.org/w/index.php?title=Talk:Hypomethylating_agent&oldid=1199996830"